BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8420020)

  • 1. Amiodarone pulmonary toxicity: a multidisciplinary review of current status.
    Fraire AE; Guntupalli KK; Greenberg SD; Cartwright J; Chasen MH
    South Med J; 1993 Jan; 86(1):67-77. PubMed ID: 8420020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of amiodarone pulmonary toxicity.
    Kennedy JI
    Clin Chest Med; 1990 Mar; 11(1):119-29. PubMed ID: 2182273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallium lung scintigraphy in amiodarone pulmonary toxicity.
    Zhu YY; Botvinick E; Dae M; Golden J; Hattner R; Scheinman M
    Chest; 1988 Jun; 93(6):1126-31. PubMed ID: 3371091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry.
    Bedrossian CW; Warren CJ; Ohar J; Bhan R
    Ann Diagn Pathol; 1997 Oct; 1(1):47-56. PubMed ID: 9869825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytology of bronchoalveolar lavage in some rare pulmonary disorders: pulmonary alveolar proteinosis and amiodarone pulmonary toxicity.
    Mermolja M; Rott T; Debeljak A
    Cytopathology; 1994 Feb; 5(1):9-16. PubMed ID: 8173037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone pulmonary toxicity.
    Marchlinski FE; Gansler TS; Waxman HL; Josephson ME
    Ann Intern Med; 1982 Dec; 97(6):839-45. PubMed ID: 7149492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late postoperative amiodarone pulmonary toxicity].
    Alonso-Fernández A; Alvarez-Sala R; Mediano O; Torres I; Moreno I
    An Med Interna; 2003 Aug; 20(8):419-20. PubMed ID: 14516264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung disease caused by amiodarone, a new antiarrythmic agent.
    Gefter WB; Epstein DM; Pietra GG; Miller WT
    Radiology; 1983 May; 147(2):339-44. PubMed ID: 6836114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytologic changes in bronchoalveolar lavage in amiodarone treated patients].
    Jolly E; Belloti MS; Lowenstein J; Luna C; Avagnina A; Elsner B; Mazzei JA
    Medicina (B Aires); 1991; 51(1):19-25. PubMed ID: 1921687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations.
    Kennedy JI; Myers JL; Plumb VJ; Fulmer JD
    Arch Intern Med; 1987 Jan; 147(1):50-5. PubMed ID: 3800529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation.
    Facchini G; Forte S; Podda P; Piro F; Carlone S
    Eur Rev Med Pharmacol Sci; 2008; 12(2):113-6. PubMed ID: 18575161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone pulmonary toxicity: clinical and subclinical features.
    Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
    Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium scintigraphy in the detection of amiodarone lung toxicity.
    Moinuddin M; Rockett J
    AJR Am J Roentgenol; 1986 Sep; 147(3):607-9. PubMed ID: 3488662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse alveolar damage syndrome associated with amiodarone therapy.
    Jirik FR; Henning H; Huckell VF; Ostrow DV
    Can Med Assoc J; 1983 May; 128(10):1192-5. PubMed ID: 6839242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of amiodarone-induced pulmonary toxicity.
    Dusman RE; Stanton MS; Miles WM; Klein LS; Zipes DP; Fineberg NS; Heger JJ
    Circulation; 1990 Jul; 82(1):51-9. PubMed ID: 2364524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of amiodarone pulmonary toxicity.
    Kudenchuk PJ; Pierson DJ; Greene HL; Graham EL; Sears GK; Trobaugh GB
    Chest; 1984 Oct; 86(4):541-8. PubMed ID: 6478892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content.
    Nicolet-Chatelain G; Prevost MC; Escamilla R; Migueres J
    Chest; 1991 Feb; 99(2):363-9. PubMed ID: 1989796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance.
    Sunderji R; Kanji Z; Gin K
    Can J Cardiol; 2000 Nov; 16(11):1435-40. PubMed ID: 11109040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone pulmonary toxicity].
    Reĭngardene DI; Azaravichene AP; Korobkova IZ
    Vestn Rentgenol Radiol; 2002; (1):43-7. PubMed ID: 12715450
    [No Abstract]   [Full Text] [Related]  

  • 20. Amiodarone: review of pulmonary effects and toxicity.
    Papiris SA; Triantafillidou C; Kolilekas L; Markoulaki D; Manali ED
    Drug Saf; 2010 Jul; 33(7):539-58. PubMed ID: 20553056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.